Forced expression of α-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions

Circulation

Volumn 111, Issue 18, 2005, Pages 2339-2346

  James, Jeanne ^a   Martin, Lisa ^a   Krenz, Maike ^a   Quatman, Carmen ^a   Jones, Fred ^a   Klevitsky, Raisa ^a   Gulick, James ^a   Robbins, Jeffrey ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Division of Molecular Cardiovascular Biology   (United States)

Author keywords

Cardiomyopathy; Heart failure; Molecular biology; Myocardial contraction

Indexed keywords

COMPLEMENTARY DNA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE; HEART PACING; HEART PROTECTION; HEART SEPTUM DEFECT; HEART VENTRICLE; HISTOLOGY; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT; STRESS; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; CARDIOTONIC AGENTS; GENE EXPRESSION; HEART VENTRICLES; MYOSIN HEAVY CHAINS; PROTEIN ISOFORMS; RABBITS; STRESS; TACHYCARDIA;

EID: 18444399318     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000164233.09448.B1     Document Type: Article

References (29)

1. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR. Changes in gene expression in the intact human heart: downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest. 1997;100:2315-2324.
2. Nakao K, Minobe W, Roden R, Bristow MR, Leinwand LA. Myosin heavy chain gene expression in human heart failure. J Clin Invest. 1997;100:2362-2370.
3. Miyata S, Minobe W, Bristow MR, Leinwand LA. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res. 2000;86:386-390.
4. Reiser PJ, Portman MA, Ning XH, Schomisch Moravec C. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am J Physiol Heart Circ Physiol. 2001;280:H1814-H1820.
5. Abraham WT, Gilbert EM, Lowes BD, Minobe WA, Larrabee P, Roden RL, Dutcher D, Sederberg J, Lindenfeld JA, Wolfel EE, Shakar SF, Ferguson D, Volkman K, Linseman JV, Quaife RA, Robertson AD, Bristow MR. Coordinate changes in myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med. 2002;8:750-760.
6. Alpert NR, Mulieri LA. Functional consequences of altered cardiac myosin isoenzymes. Med Sci Sports Exerc. 1986;18:309-313.
7. Sanbe A, James J, Tuzcu V, Nas S, Martin L, Gulick J, Osinka H, Sakthivel S, Klevitsky R, Ginsburg KS, Bers DM, Zinman B, Lakatta EG, Robbins J. Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy. Circulation. 2005;111:2330-2338.
8. James J, Sanbe A, Yager K, Martin L, Klevitsky R, Robbins J. Genetic manipulation of the rabbit heart via transgenesis. Circulation. 2000;101:1715-1721.
9. James J, Zhang Y, Wright K, Witt S, Glascock E, Osinska H, Klevitsky R, Martin L, Yager K, Sanbe A, Robbins J. Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2002;34:873-882.
10. James J, Zhang Y, Osinska H, Sanbe A, Klevitsky R, Hewett TE, Robbins J. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res. 2000;87:805-811.
11. Pardee JD, Spudich JA. Purification of muscle actin. Methods Cell Biol. 1982;24:271-289.
12. Tyska MJ, Hayes E, Giewat M, Seidman CE, Seidman JG, Warshaw DM. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res. 2000;86:737-744.
13. James J, Osinska H, Hewett TE, Kimball T, Klevitsky R, Witt S, Hall DG, Gulick J, Robbins J. Transgenic over-expression of a motor protein at high levels results in severe cardiac pathology. Transgenic Res. 1999;8:9-22.
14. Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, Neilson JR, Liberatore CM, Yutzey KE, Crabtree GR, Tsika RW, Molkentin JD. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem. 2004;279:26192-26200.
15. Gulick J, Hewett TE, Klevitsky R, Buck SH, Moss RL, Robbins J. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ Res. 1997;80:655-664.
16. Sanbe A, Nelson D, Gulick J, Setser E, Osinska H, Wang X, Hewett TE, Klevitsky R, Hayes E, Warshaw DM, Robbins J. In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy. Circ Res. 2000;87:296-302.
17. Wu Y, Bell SP, Trombitas K, Witt CC, Labeit S, LeWinter MM, Granzier H. Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness. Circulation. 2002;106:1384-1389.
18. Tibayan FA, Lai DT, Timek TA, Dagum P, Liang D, Daughters GT, Ingels NB, Miller DC. Alterations in left ventricular torsion in tachycardia-induced dilated cardiomyopathy. J Thorac Cardiovasc Surg. 2002;124:43-49.
19. Jeron A, Muders F, Schiessl A, Northeis W, Luchner A. Differential ventricular gene expression of Kv1.5 and RERG in a rabbit heart failure model associated with ventricular tachycardias and prolonged QTc interval. Pacing Clin Electrophysiol. 2001;24:580. Abstract.
20. Luchner A, Muders F, Dietl O, Friedrich E, Blumberg F, Protter AA, Riegger GA, Eisner D. Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovasc Res. 2001;51:601-607.
21. Braunwald E, Zipes DP, Libby P, eds. Braunwald: Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia, Pa: W.B. Saunders Co; 2001.
22. Snider RA, Serwer GA, Ritter SB. Echocardiography in Pediatric Heart Disease. 2nd ed. St Louis, Mo: Mosby-Year Book, Inc; 1997.
23. Harris DE, Work SS, Wright RK, Alpert NR, Warshaw DM. Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J Muscle Res Cell Motil. 1994;15:11-19.
24. Holubarsch C, Goulette RP, Litten RZ, Martin BJ, Mulieri LA, Alpert NR. The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat myocardium. Circ Res. 1985;56:78-86.
25. Alpert NR, Mulieri LA. Determinants of energy utilization in the activated myocardium. Fed Proc. 1986;45:2597-2600.
26. VanBuren P, Harris DE, Alpert NR, Warshaw DM. Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ Res. 1995;77:439-444.
27. Sugiura S, Kobayakawa N, Fujita H, Momomura S, Chaen S, Sugi H. Distinct kinetic properties of cardiac myosin isoforms revealed by in vitro studies. Adv Exp Med Biol. 1998;453:125-130.
28. Sugiura S, Kobayakawa N, Fujita H, Yamashita H, Momomura S, Chaen S, Omata M, Sugi H. Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation. Circ Res. 1998;82:1029-1034.
29. Tardiff JC, Hewett TE, Factor SM, Vikstrom KL, Robbins J, Leinwand LA. Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol. 2000;278:H412-H419.